- Home
- RHI vs HTFL Comparison
RHI vs HTFL Comparison
Compare RHI & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RHI | HTFL |
|---|---|---|
| Founded | 1948 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RHI | HTFL |
|---|---|---|
| Price | $30.82 | $29.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $30.33 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 8.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $5,378,506,000.00 | N/A |
| Revenue This Year | $1.27 | $27.66 |
| Revenue Next Year | $5.95 | $23.55 |
| P/E Ratio | $221.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.83 | $20.13 |
| 52 Week High | $45.17 | $41.22 |
Technical Indicators
Market Signals| Indicator | RHI | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 49.79 |
| Support Level | $25.93 | $28.60 |
| Resistance Level | $35.37 | $32.69 |
| Average True Range (ATR) | 1.44 | 1.84 |
| MACD | 0.34 | -0.15 |
| Stochastic Oscillator | 82.35 | 48.36 |
Price Performance
Historical ComparisonAbout RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.